下列何檢驗項目可用以區分Hereditary spherocytosis 及pyruvate kinase deficiency 所造成之溶血?
(A)Osmotic fragility test
(B)Autohemolysis test
(C)Schilling test
(D)Prussian blue stain
Rai classification 將慢性淋巴球白血病(chronic lymphocytic leukemia)分成5 期(stage),那一期病人預期的存活期最短?
(A)Stage I
(B)Stage II
(C)Stage IV
(D)Stage 0
以direct thrombin inhibitor(如Argatroban)治療heparin-induced thrombocytopenia 時,不會影響下列那個實驗室檢驗?
(A)activated partial thromboplastin
(B)prothrombin time
(C)thrombin time
(D)bleeding time
可用來排除肺動脈栓塞之檢驗為:
(A)D-dimer
(B)fibrinogen degradation product
(C)urea solubility test
(D)euglobulin clot lysis time
用來評估纖維蛋白溶解(fibrinolysis)活性的檢驗是:
(A)protamine sulfate dilution test
(B)euglobulin clot lysis time
(C)ethanol gelation test
(D)urea solubility test
Reptilase 可以切斷fibrinogen 產生下列何者?
(A)Fibrinopeptide A
(B)Fibrinopeptide B
(C)Fibrinopeptide C
(D)Fibrinopeptide A, fibrinopeptide B
下列關於International normalized ratio(INR)的敘述,何者正確?
(A)用來Regulate anticoagulation with heparin
(B)是一種將Prothrombin time ratio 標準化的方法
(C)是一種改進的表達Activated partial thromboplastin time 之方法
(D)隨Anticoagulant 強度增加而減少